Multi-omics Mendelian randomisation using expression, splicing and protein quantitative trait loci: identification of novel drug targets for gliomagenesis

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

ZAT, LJA, LP and JWR receive support from the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/4, MC_UU_00011/1). ZAT receives funding from Southmead Hospital Charitable Funds: Brain tumour bank and research fund 8036. LJA and KMK are funded by Cancer Research UK (grant number C30758/A29791). JWR received funding from Biogen for unrelated projects. KMK is funded by Innovate (grant number 10027624). This study was supported by the National Institute for Health and Care Research Bristol Biomedical Research Centre (NIHR203315) and Cancer Research UK (grant number C18281/A29019 and C18281/A30905). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The MetaBrain meta-analyses eQTL data can be accessed at https://www.metabrain.nl/. The GTEx sQTL v8 data can be accessed at https://gtexportal.org/home/datasets. The BrainQTL pQTL data can be found at https://www.synapse.org/#!Synapse:syn24172458. The NIAGADS pQTL data can be found at https://www.niagads.org/datasets/ng00102. The glioma data may be accessed under the European Genome-phenome Archive accession number EGAD00010001657 (https://www.ebi.ac.uk/ega/datasets/EGAD00010001657).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes